Association of circulating fractalkine (CX3CL1) and CX3CR1+CD4+ T cells with common carotid artery intima-media thickness in patients with chronic kidney disease

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 11, 2011, Pages 958-965

  Yadav, Ashok Kumar ^a   Lal, Anupam ^a   Jha, Vivekanand ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Atherosclerosis; Chronic kidney disease; Fractalkine; Inflammation

Indexed keywords

C REACTIVE PROTEIN; CD28 ANTIGEN; FRACTALKINE;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; CD4+ T LYMPHOCYTE; CELL POPULATION; CHRONIC KIDNEY DISEASE; COMMON CAROTID ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ULTRASOUND;

EID: 82455164442     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.8722     Document Type: Article

References (27)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004; 351: 1296-1305
2. Dumitriu IE, Araguas ET, Baboonian C, Kaski JC: CD4+ CD28 null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res, 2009; 81: 11-19
3. Goda S, Imai T, Yoshie O, Yoneda O, Inoue H, Nagano Y, Okazaki T, Imai H, Bloom ET, Domae N, Umehara H: CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J Immunol, 2000; 164: 4313-4320
4. Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshie O, Imai T: Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol, 2004; 24: 34-40
5. Greaves DR, Hakkinen T, Lucas AD, Liddiard K, Jones E,Quinn CM, Senaratne J, Green FR, Tyson K, Boyle J, Shanahan C, Weissberg PL, Gordon S, Yla-Hertualla S: Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 2001; 21: 923-929
6. Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, Greaves DR: Smooth muscle cells in human athero-sclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation, 2003; 108: 2498-2504
7. McDermott DH, Halcox JP, Schenke WH, Waclawiw MA, Merrell MN, Epstein N, Quyyumi AA, Murphy PM: Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res, 2001; 89: 401-407
8. Pingiotti E, Cipriani P, Marrelli A, Liakouli V, Fratini S, Penco M, Giacomelli R. Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage. Ann N Y Acad Sci 2007; 1107: 32-41
9. Kobayashi T, Okamoto S, Iwakami Y, Nakazawa A, Hisa-matsu T, Chinen H, Kamada N, Imai T, Goto H, Hibi T:Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm Bowel Dis, 2007; 13: 837-846
10. Sawai H, Park YW, Roberson J, Imai T, Goronzy JJ, Weyand CM: T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. Arthritis Rheum, 2005; 52: 1392-1401
11. Jairam A, Das R, Aggarwal PK, Kohli HS, Gupta KL, Sakhuja V, Jha V: Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy. Indian J Nephrol, 2010; 20: 125-131
12. Namekawa T, Snyder MR, Yen JH, Goehring BE, Leibson PJ, Weyand CM, Goronzy JJ: Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 2000; 165: 1138-1145
13. Yadav AK, Jha V: CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patient on peritoneal dialysis. Nephrol Dial Transplant, 2011; 26: 1689-1694
14. Damas JK, Boullier A, Waehre T, Smith C, Sandberg WJ, Green S, Aukrust P, Quehenberger O: Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler Thromb Vasc Biol, 2005; 25: 2567-2572
15. Ikejima H, Imanishi T, Tsujioka H, Kashiwagi M, Kuroi A, Tanimoto T, Kitabata H, Ishibashi K, Komukai K, Takeshita T, Akasaka T: Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris. Circ J, 2010; 74: 337-345
16. Nanki T, Imai T, Nagasaka K, Urasaki Y, Nonomura Y,Taniguchi K, Hayashida K, Hasegawa J, Yoshie O, Miyasaka N: Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. Arthritis Rheum, 2002; 46: 2878-2883
17. Hasegawa M, Sato S, Echigo T, Hamaguchi Y, Yasui M, Takehara K: Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis. Ann Rheum Dis, 2005; 64: 21-28
18. Bjerkeli V, Damas JK, Fevang B, Holter JC, Aukrust P, Froland SS: Increased expression of fractalkine (CX3CL1)and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation. Rheumatology (Oxford), 2007; 46: 1422-1427
19. Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, Marchesi S, Pirro M, Ragni F, Shoenfeld Y, Mannarino E: CD4+CD28-T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation, 2004; 109: 2744-2748
20. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM: Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation, 2000; 101: 2883-2888
21. Betjes MG, Huisman M, Weimar W, Litjens NH: Expansion of cytolytic CD4+CD28-T cells in end-stage renal disease. Kidney Int, 2008; 74: 760-767
22. Komocsi A, Lamprecht P, Csernok E, Mueller A, Holl- Ulrich K, Seitzer U, Moosig F, Schnabel A, Gross WL:Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol, 2002; 160: 1717-1724
23. Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R: CD4+CD28-costimulation-independent T cells in multiple sclerosis. J Clin Invest, 2001; 108: 1185-1194
24. Schmidt D, Goronzy JJ, Weyand CM: CD4+ CD7-CD28-T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest, 1996; 97: 2027-2037
25. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM: CD4+CD28-T cells in rheumatoid arthritis patientscombine features of the innate and adaptive immune systems. Arthritis Rheum, 2001; 44: 13-20
26. Grip O, Janciauskiene S, Bredberg A: Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease. Br J Pharmacol, 2008; 155: 1085-1092
27. Chen YM, Tu CJ, Hung KY, Wu KD, Tsai TJ, Hsieh BS: Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells:evidence for mediation by NF-kappa B down-regulation. Br J Pharmacol, 2003; 138: 950-958.